OTC Markets Group (OTCM) Q4 2024 earnings summary

Executive summary

• Achieved record annual revenues of $111.1 million in 2024, up 1% year-over-year, driven by strong OTC Link performance and stable market data licensing, while corporate services revenue declined and net income fell 1% to $27.4 million.

• Operating margin for 2024 was 29.9%, down from 30.6% in 2023, with diluted EPS at $2.26 and adjusted diluted EPS up 1% to $3.41.

• Board declared a quarterly dividend of $0.18 per share for Q1 2025 and continued share repurchases, returning $29.5 million to shareholders.

• Strategic priorities for 2025 include OTC Overnight trading, the launch of the OTCID Basic Reporting Market, and enhancing client connections and operational risk management.

• No major acquisitions or divestitures occurred in 2024; 43 companies graduated to a national securities exchange.

Financial highlights

• Q4 2024 gross revenues were $28.5 million, up 3% year-over-year; full-year gross revenues reached $111.1 million, up 1%.

• Adjusted EBITDA for 2024 was $41.3 million, up 1% year-over-year; adjusted diluted EPS was $3.41.

• Cash flows from operations were $32.9 million; free cash flow was $31.6 million.

• FY 2024 operating expenses totaled $69.0 million, with compensation and benefits comprising 64%.

• Cash and cash equivalents at year-end were $34.5 million.

Outlook and guidance

• Focused on sustainable growth through product improvement, operational efficiency, and investment in IT infrastructure and human capital.

• OTCID Basic Reporting Market launch set for July 1, 2025, replacing the Pink Current Market, with minimal expected revenue reporting changes.

• Ongoing focus on growing shareholder returns and utilizing buybacks for employee liquidity.